Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Bankers say a lack of investor confidence makes bigger deals more challenging -
The Saudi drug maker's IPO is the first major flotation in the country this year
-
Fourth biggest bond ever needed new pricing approach to work
-
2023 has been a slow year for Saudi Arabia's IPO market
-
In a block trade, GSK sold 2.6% of its former joint venture with Pfizer
-
After a blowout 2022, the pace of issuance in Saudi equity capital markets has slowed this year
